Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis.
Jung
N
N
Owczarczyk
K
K
Hellmann
M
M
Lehmann
C
C
Fätkenheuer
G
G
Hallek
M
M
Rubbert
A
A
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001228:Aspergillosis / Q000150:complications*; D005260:Female; D006801:Humans; D008172:Lung Diseases, Fungal / Q000150:complications*; D008875:Middle Aged; D009894:Opportunistic Infections / Q000150:complications; D000069283:Rituximab; D014397:Tuberculosis, Pulmonary / Q000150:complications*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab